Rheumatology Doctors in Onalaska, WI Accepting Medicare

6 Rheumatology doctors found. Showing 1 - 6

Jack M Lockhart, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 3111 Gundersen Dr, Onalaska, WI 54650 Phone: 608-775-8630

Dr. Robert C Uchiyama, M. D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 191 Theater Rd, Onalaska, WI 54650 Phone: 608-785-0940

Dr. Douglas W White, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3111 Gundersen Dr, Onalaska, WI 54650 Phone: 608-775-8100

Carol L. Young, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3111 Gundersen Dr, Onalaska, WI 54650 Phone: 608-775-8100

Sreekanth Chintamaneni, M.D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 3111 Gundersen Dr, Onalaska, WI 54650 Phone: 608-775-8100

Huzaif Qaisar, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 191 Theater Rd, Onalaska, WI 54650 Phone: 608-392-5000

News Archive

New EDUCARE project to train healthcare workers combat cancer epidemic in Africa

Roche announced today the launch of the EDUCARE project, which, in concert with IAEA, will provide support to help combat the growing cancer epidemic in sub-Saharan Africa.

Actavis announces FDA approval of VIBERZI (eluxadoline) for IBS-D treatment

Actavis plc announced today that VIBERZI (eluxadoline) was approved by the Food and Drug Administration as a twice-daily, oral treatment for adults suffering from irritable bowel syndrome with diarrhea (IBS-D). VIBERZI (eluxadoline) has mixed opioid receptor activity, it is a mu receptor agonist, a delta receptor antagonist, and a kappa receptor agonist.

Supplement intake predicts optimal RBC folate concentration in Canadian women

Researchers have gained new insight into why 22% of Canadian women of childbearing age are still not achieving a folate concentration considered optimal for reducing the risk of having babies with neural tube defects, despite a virtual absence of folate deficiency in the general Canadian population.

University of Kentucky physician revolutionizes gene research

A dramatic new study published in the most recent issue of Nature questions some of the mechanisms underlying a new class of drugs based on Nobel Prize-winning work designed to fight diseases ranging from macular degeneration to diabetes.

Read more Medical News

› Verified 2 days ago